Leonteq Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Leonteq Securities's BIIB Position: Q3 2026 in Review
Leonteq Securities increased its Biogen (BIIB) stake by 6.5% in Q3 2026, buying an estimated $295K and bringing the position to 22,747 shares worth $5.14M. The position accounts for 0.21% of the portfolio, ranked #92.
Leonteq Securities first reported a position in BIIB in Q2 2021 and has held it in 21 quarters since. The position peaked at $25.9M in Q1 2022. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Leonteq Securities held 22,747 shares of Biogen worth $5.14M as of Q3 2026.
- Leonteq Securities bought 1,393 Biogen shares in Q3 2026, an estimated $295K.
- Biogen made up 0.21% of Leonteq Securities's portfolio in Q3 2026, its #92 holding.
- Leonteq Securities first reported a position in Biogen in Q2 2021 and has held it in 21 quarters since.
- Leonteq Securities's Biogen position peaked at $25.9M in Q1 2022.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.